FierceBiotech

Half a year after being spurned by the FDA and [...]

Ambrosia Biosciences is aiming to move the market beyond peptide-based [...]

Eli Lilly has gone big in the name of neuroscience, [...]

Astellas Pharma has become the latest company to pull back [...]

One of the world’s leading investment firms has broken its [...]

Autoimmune specialist Aurinia, which named Kevin Tang as its new [...]

AstraZeneca isn’t letting a death in a China trial detract [...]

Otsuka Pharmaceutical has acquired Transcend Therapeutics for $700 million upfront [...]

Takeda has posted phase 3 data on an autoimmune asset [...]

AstraZeneca’s chronic obstructive pulmonary disease drug candidate has hit the [...]